Recent Updates
Recently added Catalysts
IRWD Positive Sentiment

Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call

Thursday, July 30, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ironwood Pharmaceuticals has announced its second quarter 2026 investor update call, scheduled for August 6, 2026, at 8:30 a.m. Eastern Time. The call will be accessible via phone and webcast, demonstrating the company's commitment to investor relations. Participants can join using specific dial-in numbers and a conference ID.

Market Sentiment Analysis

POSITIVE FACTORS

  • Ironwood Pharmaceuticals is actively engaging with investors.
  • The scheduled call indicates transparency and communication.
  • The event is set for a future date, showing planning and organization.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+44%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 2 · Gastroesophageal Reflux Disease

Full Press Release Details

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced it will host its second quarter 2026 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 6, 2026. Individuals interested in participating in the call should dial (888) 596-4144 (U.S.) or (646) 968-2525 (international) using conference ID number and event passcode 3647053. To access the webcast, please visit the Investors & Media section of Ironwood’s website at www.i

Frequently Asked Questions

When is the Ironwood investor update call scheduled?

The investor update call is scheduled for August 6, 2026.

How can I join the Ironwood investor call?

You can join by dialing specific phone numbers or via the webcast on their website.

What time will the Ironwood investor call take place?

The call will take place at 8:30 a.m. Eastern Time.

What is the conference ID for the Ironwood call?

The conference ID for the call is 3647053.

ShareAdd on Google
Tags: IRWD Viatris Investor Conferences Healthcare Ironwood Pharmaceuticals investor update conference call 2026
Last updated: Jul 30, 2026

Biotech snapshot

Cash runway
$220M liquidity · $0M/mo burn
Low dilution risk
Lead asset
IW-3718Phase 2
Gastroesophageal Reflux Disease →

Catalyst track record

+44%
best trade around IRWD's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IRWD.

See every catalyst's timing & PoA →